FDA Inspection 937012 — Changzhou Ruiming Pharmaceuticals Co. Ltd.
The FDA completed an inspection of Changzhou Ruiming Pharmaceuticals Co. Ltd. on Jul 17, 2015 in Changzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 17, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Changzhou (China)